Endothelial dysfunction in preeclampsia. Part I: Primary prevention. Therapeutic perspectives (Q40959095)

25 September 2017

1 reference

title

Endothelial dysfunction in preeclampsia. Part I: Primary prevention. Therapeutic perspectives (English)

1 reference

25 September 2017

0 references

0 references

Dekker GA

1 reference

25 September 2017

van Geijn HP

series ordinal

1 reference

25 September 2017

publication date

1 January 1996

1 reference

Journal of Perinatal Medicine

25 September 2017

published in

1 reference

25 September 2017

1 reference

25 September 2017

1 reference

25 September 2017

page(s)

99-117

1 reference

Myocardial reperfusion injury: mechanisms and management--a review

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Which plasma factors bring about disturbance of endothelial function in pre-eclampsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Pre-eclampsia is associated with an increase in trophoblast glycogen content and glycogen synthase activity, similar to that found in hydatidiform moles

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Predictive value of increased plasma levels of fibronectin in gestational hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Endomyocardial ultrastructural findings in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Towards the physiological function of uric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Myocardial glutathione depletion impairs recovery after short periods of ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Endothelium-dependent vascular responses. Mediators and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

The pharmacological prevention of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Retinopathy of prematurity--current diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Clinical pharmacokinetics of N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Lipid peroxidation in pregnancy: new perspectives on preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Protective effect of vitamin E on fetal distress induced by ischemia of the uteroplacental system in pregnant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Oxygen radicals in CNS damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Oxidation of membrane cholesterol alters active and passive transsarcolemmal calcium movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Anti-vascular endothelial cell antibodies in severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Vitamin E consumption and the risk of coronary heart disease in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Preeclampsia: an endothelial cell disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

N-acetyl-L-cysteine protects endothelial cells but not L929 tumor cells from tumor necrosis factor-alpha-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Transplacental transport of N-acetylcysteine in an ovine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Ultrastructural aspects of preeclampsia. II. Mitochondrial changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Oxidative stress: from basic research to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Vitamin E consumption and the risk of coronary disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Growth factor activity in the blood of women in whom preeclampsia develops is elevated from early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Pre-eclampsia--a mitochondrial disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Regulatory functions of the vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Preeclampsia: an imbalance in placental prostacyclin and thromboxane production

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Maternal levels of prostacyclin, thromboxane, vitamin E, and lipid peroxides throughout normal pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Mechanisms of endothelial cell killing by H2O2 or products of activated neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

Oxygen-derived free radicals in postischemic tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

N-Acetylcysteine and glutathione as inhibitors of tumor necrosis factor production

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPME.1996.24.2.99

10.1515/JPME.1996.24.2.99

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference